Toyota investing $1.3 billion in Kentucky to construct all-electric, three-row SUV

Toyota investing .3 billion in Kentucky to construct all-electric, three-row SUV


Akio Toyoda, Chairman of Toyota Motor Corp.

Yoshikazu Tsuno | Gamma-rapho | Getty Photographs

Toyota Motor is investing $1.3 billion in a Kentucky plant to make a new all-electric, three-row SUV for the U.S. current market, the company reported Tuesday.

The car or truck is envisioned to go into manufacturing in between late 2025 and early 2026, in accordance to a corporation spokeswoman. It is section of earlier declared designs by the Japanese automaker to commit $35 billion in battery-electrical vehicles, or BEVs, as a result of 2030.

A firm spokesperson declined to give more details of the forthcoming motor vehicle, which will possible contend in opposition to latest motor vehicles this kind of as the Rivian RST and Kia EV9.

The announcement arrives as buyer adoption for EVs has been slower than many envisioned, producing some automakers to delay or slice expense programs for all-electric autos.

Toyota – the world’s greatest automaker – is among the the most prominent automakers to say that even though EVs are a solution to arrive at carbon neutrality, they’re not the only one. The automaker carries on to devote in hybrids, plug-in hybrid vehicles and other technologies these as hydrogen gas cells.



Resource

‘Draconian development’ in Meta-Manus deal draws the line in China’s AI race with the U.S.
World

‘Draconian development’ in Meta-Manus deal draws the line in China’s AI race with the U.S.

Manus was hailed by Chinese state media as the “next DeepSeek” soon after its launch in March 2025, months before the startup relocated to Singapore. Cheng Xin | Getty Images News | Getty Images BEIJING — China’s decision to block U.S. tech giant Meta‘s $2 billion acquisition of artificial intelligence startup Manus is being seen […]

Read More
Novartis CEO warns reality of Trump’s drug pricing policy will set in over ‘the next 18 months’
World

Novartis CEO warns reality of Trump’s drug pricing policy will set in over ‘the next 18 months’

Novartis‘ CEO warned Tuesday that the U.S. drug pricing policy under President Donald Trump poses a “very difficult situation” and the reality will soon catch up with both drugmakers and patients. “The longer-term implications are significant,” CEO Vas Narasimhan told CNBC’s Carolin Roth. Novartis is focused on getting European and Japanese governments to quickly change […]

Read More
CNBC Daily Open: Hawkish hold from BOJ sets central bank stage
World

CNBC Daily Open: Hawkish hold from BOJ sets central bank stage

The Bank of Japan headquarters in Tokyo on May 30, 2024. Kazuhiro Nogi | Afp | Getty Images Hello, this is Katie Foley writing to you from London. I spend my mornings leading the London TV teams as we prepare to take Europe Early Edition and Squawk Box Europe to air. Over the last two […]

Read More